- Industry representatives believe that CBD has become “too big to fail” as a result of the legislative changes that occurred at the end of 2018
- Since hemp has been taken off the controlled substances list, the CBD market is anticipated to grow rapidly and reach $22 billion by 2022
- These changes will lead to intense competition and the need for more effective cultivation methods; because of such trends, companies like Green Hygienics Holdings are expected to benefit from rapid growth opportunities in 2019 and beyond
The legal status of hemp finally changed at the end of 2018, and, according to analysts, CBD products will grow to be bigger than ever before in 2019 and the years to come. This is good news for companies such as Green Hygienics Holdings Inc. (OTCQB: GRYN), which are expected to profit from new growth opportunities as a result of the legislative changes.
The popularity of CBD is growing, and it has now become “too big to fail,” as U.S. Hemp Roundtable general counsel Jonathan Miller was quoted as saying in a Quartz article (http://ibn.fm/b00OG). Market projections for hemp-derived CBD suggest that it will reach $22 billion in the U.S. by 2022.
President Donald Trump signed the new Federal Farm Bill on December 20, 2018. The bill takes hemp off the controlled substances list, liberalizing the market and enabling large-scale cultivation, rather than just clinical or experimental projects.
In addition, the Food and Drug Administration (FDA) issued a statement indicating that public meetings will be held for the purpose of creating a framework for the federal regulation of products featuring CBD oil. “We see a path in the very near future that the FDA will be formally approving of these products to be sold alongside the vitamin Cs and Ds and melatonins of the world,” Miller added.
The new legislative landscape will provide significant growth opportunities for companies like Green Hygienics. As the market expands and the competition becomes fiercer than ever before, the method and the cost of cultivation will become two of the determinants for success.
Green Hygienics offers cost-efficient growth solutions, and the company targets the high-end medical and adult-use recreational sectors. Its corporate strategy revolves around the use of hygienics and commercial indoor cultivation while optimizing yields.
The company relies on the aeroponic method of cultivation. Under this method, the roots of the plant are exposed, and the air is permeated by a mist of nutrients. The Green Hygienics proprietary aeroponics cultivation system provides a direct feed to the roots of the plant, and a centralized system is utilized to ensure optimal growth conditions – moisture, temperature, etc.
The result of using this proprietary aeroponics system is that a consistent grade of product can be delivered with both superior quality and superior yield in comparison to traditional cultivation methods.
Aeroponics systems operate in controlled, protected environments. Thus, many variables are eliminated to ensure cultivation consistency. The advanced, science-driven cultivation system brings the production cost per gram to under one dollar. In comparison, direct competitors that cultivate indoor products have reached a production cost per gram in the $2-$4 range.
Green Hygienics aims to grow in 2019 and beyond by generating revenue from the cultivation and sale of premium grade cannabis-derived products. In addition, Green Hygienics plans to develop and license intellectual property assets, make strategic acquisitions and develop globally-trusted consumer brands.
For more information, visit the company’s website at www.GreenHygienicsHoldings.com
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.